Literature DB >> 22809923

Ventilator-associated pneumonia caused by Pseudomonas aeruginosa: cap your needles!

Alan R Hauser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22809923      PMCID： PMC4151310          DOI： 10.1097/CCM.0b013e318258e5bb

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  16 in total

1.  Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes.

Authors:  Julien Goure; Petr Broz; Olivier Attree; Guy R Cornelis; Ina Attree
Journal:  J Infect Dis       Date:  2005-06-07       Impact factor: 5.226

2.  Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial.

Authors:  Bruno François; Charles-Edouard Luyt; Anthony Dugard; Michel Wolff; Jean-Luc Diehl; Samir Jaber; Jean-Marie Forel; Denis Garot; Eric Kipnis; Alexandre Mebazaa; Benoit Misset; Antoine Andremont; Marie-Cécile Ploy; Alan Jacobs; Geoffrey Yarranton; Tillman Pearce; Jean-Yves Fagon; Jean Chastre
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

3.  Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury.

Authors:  T Sawa; T L Yahr; M Ohara; K Kurahashi; M A Gropper; J P Wiener-Kronish; D W Frank
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

4.  Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.

Authors:  N Shime; T Sawa; J Fujimoto; K Faure; L R Allmond; T Karaca; B L Swanson; E G Spack; J P Wiener-Kronish
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

5.  Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.

Authors:  Ali A El-Solh; Angela Hattemer; Alan R Hauser; Ahmad Alhajhusain; Hardik Vora
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

Review 6.  Targeting mechanisms of Pseudomonas aeruginosa pathogenesis.

Authors:  E Kipnis; T Sawa; J Wiener-Kronish
Journal:  Med Mal Infect       Date:  2006-01-19       Impact factor: 2.152

Review 7.  Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.

Authors:  Jeffrey L Veesenmeyer; Alan R Hauser; Thiago Lisboa; Jordi Rello
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

8.  Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.

Authors:  Dara W Frank; Amy Vallis; Jeanine P Wiener-Kronish; Arup Roy-Burman; Edward G Spack; Brian P Mullaney; Mehdi Megdoud; James D Marks; Robert Fritz; Teiji Sawa
Journal:  J Infect Dis       Date:  2002-06-14       Impact factor: 5.226

Review 9.  The type III secretion system of Pseudomonas aeruginosa: infection by injection.

Authors:  Alan R Hauser
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

10.  Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model.

Authors:  Karine Faure; Junichi Fujimoto; David W Shimabukuro; Temitayo Ajayi; Nobuaki Shime; Kiyoshi Moriyama; Edward G Spack; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  J Immune Based Ther Vaccines       Date:  2003-08-13
View more
  2 in total

1.  Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.

Authors:  Perrine Bortolotti; Benjamin Hennart; Camille Thieffry; Guillaume Jausions; Emmanuel Faure; Teddy Grandjean; Marion Thepaut; Rodrigue Dessein; Delphine Allorge; Benoit P Guery; Karine Faure; Eric Kipnis; Bertrand Toussaint; Audrey Le Gouellec
Journal:  BMC Microbiol       Date:  2016-07-08       Impact factor: 3.605

Review 2.  Drosophila as a Model for Infectious Diseases.

Authors:  J Michael Harnish; Nichole Link; Shinya Yamamoto
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.